Sarah Elton-Farr | Head of Investor Relations |
Emma Walmsley | Chief Executive Officer |
Iain Mackay | Chief Financial Officer |
Luke Miels | President, Global Pharmaceuticals |
David Redfern | Chief Strategy Officer |
Brian McNamara | Chief Executive Officer, Consumer Healthcare |
Hal Barron | Chief Scientific Officer, President of R&D and Director |
Keyur Parekh | Goldman Sachs Group |
Graham Parry | Bank of America |
Tim Anderson | Wolfe Research |
James Gordon | JPMorgan |
Steve Scala | Cowen |
Andrew Baum | Citi |
Kerry Holford | Berenberg |
Good afternoon, ladies and gentlemen, and welcome to the analyst call on the GSK Third Quarter 2020 Results. I will now hand over to Sarah Elton-Farr, Head of Investor Relations, who will introduce today's session. Please go ahead Sarah.
Thank you. Good morning and good afternoon.